Future directions for ensuring viral safety of biopharmaceuticals.
Trent
D W
DW
Division of Viral Products, CBER/FDA, Rockville, MD, USA.
D000818:Animals; D001688:Biological Products / Q000592:standards*; D002460:Cell Line / Q000821:virology; D006801:Humans; D013678:Technology, Pharmaceutical / Q000639:trends*; D014780:Viruses / Q000302:isolation & purification*
D001688:Biological Products